Lorazepam Tablet
Product Images NDC 70518-1520

3 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 70518-1520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lorazepam 0.5mg 70518 1520 01

Lorazepam 0.5mg 70518 1520 01
Lorazepam 0.5 mg oral tablets packaging label showing 30 tablets, classified as a Schedule IV controlled substance. The label includes the NDC number 70518-1520-01, manufacturer details (Leading, Fairfield, NJ), and repackaging information by RemedyRepack Inc., Indiana. Directions for use refer to the package insert, and a caution about drug transfer is noted.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Lorazepam 0.5 mg tablet label from RemedyRepack Inc. The label shows the drug name, strength (0.5 mg), dosage form (tablet), quantity (30), and schedule classification (C-IV). It includes the NDC number 70518-1520-00 and packaging instructions, along with a QR code and a barcode. The label also notes repackaging by RemedyRepack, with manufacturing information for Leading, Fairfield, NJ.*
FDA Label Image

Lorazepam Structure (Lorazepam Structure)

Lorazepam Structure (Lorazepam Structure)
Chemical structure of lorazepam showing its molecular formula C15H10Cl2N2O2 and molecular weight of 321.16. The diagram includes two chlorinated aromatic rings and characteristic functional groups of the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.